An important message regarding the current COVID-19 pandemic. Click here to read more.

Heart Failure



A life-threatening illness in a poorly compliant patient. Are you up to the task?

  1. Atrial Fibrillation
  2. Brain natriuretic peptide
  3. CHADS2 score
  4. Cardiac remodeling
  5. Heart failure
  6. Major bleeding
  7. Novel oral anticoagulants
  8. Radiofrequency ablation
  9. Retroperitoneal hematoma
  10. Stroke in atrial fibrillation
  1. ANDRADE JG, KHAIRY P, GUERRA PG, DEYELL MW, RIVARD L, MACLE L, THIBAULT B, TALAJIC M, ROY D, DUBUC M. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm [online] 2011 Sep, 8(9):1444-51 [viewed 23 June 2016] Available from:
  2. CONNOLLY SJ, EZEKOWITZ MD, YUSUF S, EIKELBOOM J, OLDGREN J, PAREKH A, POGUE J, REILLY PA, THEMELES E, VARRONE J, WANG S, ALINGS M, XAVIER D, ZHU J, DIAZ R, LEWIS BS, DARIUS H, DIENER HC, JOYNER CD, WALLENTIN L, RE-LY STEERING COMMITTEE AND INVESTIGATORS. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med [online] 2009 Sep 17, 361(12):1139-51 [viewed 23 June 2016] Available from:
  3. GATTELLARI M, GOUMAS C, AITKEN R, WORTHINGTON JM. Outcomes for patients with ischaemic stroke and atrial fibrillation: the PRISM study (A Program of Research Informing Stroke Management). Cerebrovasc Dis [online] 2011, 32(4):370-82 [viewed 23 June 2016] Available from:
  4. HAïSSAGUERRE M, JAïS P, SHAH DC, TAKAHASHI A, HOCINI M, QUINIOU G, GARRIGUE S, LE MOUROUX A, LE MéTAYER P, CLéMENTY J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med [online] 1998 Sep 3, 339(10):659-66 [viewed 23 June 2016] Available from:
  5. HOLMES DAVID R, REDDY VIVEK Y, TURI ZOLTAN G, DOSHI SHEPHAL K, SIEVERT HORST, BUCHBINDER MAURICE, MULLIN CHRISTOPHER M, SICK PETER. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. The Lancet [online] 2009 August, 374(9689):534-542 [viewed 23 June 2016] Available from: doi:10.1016/S0140-6736(09)61343-X
  6. MAGNUSSON M., MELANDER O., ISRAELSSON B., GRUBB A., GROOP L., JOVINGE S.. Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease. Diabetes Care [online] December, 27(8):1929-1935 [viewed 22 June 2016] Available from: doi:10.2337/diacare.27.8.1929
  7. MARUYAMA T, ABE M, FURUKAWA T, KOBAYASHI S, YOSHIDA Y, NODA H, OKADA K, SOMA M. Retroperitoneal Hematoma in a Patient with Advanced Chronic Kidney Disease Receiving Warfarin Therapy. Intern Med [online] 2016, 55(9):1153-8 [viewed 14 July 2016] Available from:
  8. ROSSING K, BOSSELMANN HS, GUSTAFSSON F, ZHANG ZY, GU YM, KUZNETSOVA T, NKUIPOU-KENFACK E, MISCHAK H, STAESSEN JA, KOECK T, SCHOU M. Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction. PLoS One [online] 2016, 11(6):e0157167 [viewed 22 June 2016] Available from:
  9. RUFF CHRISTIAN T, GIUGLIANO ROBERT P, BRAUNWALD EUGENE, HOFFMAN ELAINE B, DEENADAYALU NAVEEN, EZEKOWITZ MICHAEL D, CAMM A JOHN, WEITZ JEFFREY I, LEWIS BASIL S, PARKHOMENKO ALEXANDER, YAMASHITA TAKESHI, ANTMAN ELLIOTT M. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. The Lancet [online] 2014 March, 383(9921):955-962 [viewed 23 June 2016] Available from: doi:10.1016/S0140-6736(13)62343-0